| AMUSX | UGSFX | AMUSX / UGSFX | |
| Total Expense Ratio | 0.66 | 0.69 | 96% |
| Annual Report Gross Expense Ratio | 0.70 | 0.73 | 96% |
| Fund Existence | 40 years | 25 years | - |
| Gain YTD | 6.669 | 6.718 | 99% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 23.8B | 23.8B | 100% |
| Annual Yield % from dividends | 3.98 | 3.94 | 101% |
| Returns for 1 year | 6.77 | 6.73 | 101% |
| Returns for 3 years | 11.17 | 11.09 | 101% |
| Returns for 5 years | -6.27 | -6.39 | 98% |
| Returns for 10 years | 6.79 | 6.67 | 102% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LFSC | 34.39 | 0.33 | +0.96% |
| F/m Emerald Life Sciences Innovation ETF | |||
| ILCB | 91.76 | 0.25 | +0.27% |
| iShares Morningstar U.S. Equity ETF | |||
| FLRG | 37.19 | 0.06 | +0.16% |
| Fidelity U.S. Multifactor ETF | |||
| WSML | 29.46 | -0.04 | -0.13% |
| iShares MSCI World Small-Cap ETF | |||
| BKSE | 106.63 | -0.48 | -0.45% |
| BNY Mellon US Small Cap Core Equity ETF | |||